The DOI matches its Crossref record; 120 of the 120 references it cites were found in a registry or an index.
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
Abstract
FBW7 (F-box and WD repeat domain-containing 7) is the substrate recognition component of an evolutionary conserved SCF (complex of SKP1, CUL1 and F-box protein)-type ubiquitin ligase. SCF(FBW7) degrades several proto-oncogenes that function in cellular growth and division pathways, including MYC, cyclin E, Notch and JUN. FBW7 is also a tumour suppressor, the regulatory network of which is perturbed in many human malignancies. Numerous cancer-associated mutations in FBW7 and its substrates have been identified, and loss of FBW7 function causes chromosomal instability and tumorigenesis. This Review focuses on structural and functional aspects of FBW7 and its role in the development of cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FBXW7 ubiquitin ligase is a component of the SCF complex and mediates degradation of several cell cycle proteins,158 and its β-isoform is induced by p53.159”
From Census and evaluation of p53 target genes (2017) · cites this paper as [158]
Citations
Cites
Notch Signaling: Cell Fate Control and Signal Integration in Development
Artavanis-Tsakonas, S., Rand, M. D., & Lake, R. J. (1999) · Science · doi:10.1126/science.284.5415.770 · Cited by 5,909
AP-1 as a regulator of cell life and death
Shaulian, E., & Karin, M. (2002) · Nature Cell Biology · doi:10.1038/ncb0502-e131 · Cited by 2,961 · cited 1×
“Many mitogens induce JUN activity, and JUN functions as part of the AP1 transcription factor to exert its positive effect on cell proliferatio”
BackgroundActivating Mutations of NOTCH1 in Human T Cell Acute Lymphoblastic Leukemia
Weng, A. P., Ferrando, A. A., Lee, W., Morris, J. P., Silverman, L. B., Sanchez-Irizarry, C., Blacklow, S. C., Look, A. T., & Aster, J. C. (2004) · Science · doi:10.1126/science.1102160 · Cited by 2,706
PI3K/Akt signalling pathway and cancer
Vara, J. Á. F., Casado, E., de Castro, J., Cejas, P., Belda-Iniesta, C., & González-Barón, M. (2003) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2003.07.007 · Cited by 2,489
Genetic Control of the Cell Division Cycle in Yeast
Hartwell, L. H., Culotti, J. G., Pringle, J. R., & Reid, B. J. (1974) · Science · doi:10.1126/science.183.4120.46 · Cited by 1,567
Structure of the Cul1–Rbx1–Skp1–F boxSkp2 SCF ubiquitin ligase complex
Zheng, N., Schulman, B. A., Song, L., Miller, J. J., Jeffrey, P. D., Wang, P., Chu, C., Koepp, D. M., Elledge, S. J., Pagano, M., et al. (2002) · Nature · doi:10.1038/416703a · Cited by 1,507
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,493
Ubiquitin ligases: cell-cycle control and cancer
Nakayama, K. I., & Nakayama, K. (2006) · Nature reviews. Cancer · doi:10.1038/nrc1881 · Cited by 1,450
Bai, C., Sen, P., Hofmann, K., Ma, L., Goebl, M. G., Harper, J. W., & Elledge, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)80098-7 · Cited by 1,421
Multiple Ras-dependent phosphorylation pathways regulate Myc protein stabilityPreprint
Sears, R. C., Nuckolls, F., Haura, E. B., Taya, Y., Tamai, K., & Nevins, J. R. (2000) · Genes & Development · doi:10.1101/gad.836800 · Cited by 1,411
Flagged first, then by citations
Cited by
Sorted by citations
Items 401–500 of 1,000
miR-23a, a Critical Regulator of “migR”ation and Metastasis in Colorectal Cancer
Wang, Z., Wei, W., & Sarkar, F. H. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0177 · Cited by 44
Quality control of protein complex composition
Padovani, C., Jevtić, P., & Rapé, M. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.02.029 · Cited by 46
Proteostasis and Its Role in Disease Development
Shukla, M., & Narayan, M. (2024) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-024-01581-6 · Cited by 46
Role of key regulators of the cell cycle in maintenance of hematopoietic stem cells
Matsumoto, A., & Nakayama, K. I. (2012) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2012.07.004 · Cited by 43
Targeting Notch degradation system provides promise for breast cancer therapeutics
Liu, J., Shen, J., Wen, X.-F., Guo, Y., & Zhang, G. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.05.010 · Cited by 45
Cathepsin V suppresses GATA3 protein expression in luminal A breast cancer
Sereesongsaeng, N., McDowell, S. H., Burrows, J. F., Scott, C. J., & Burden, R. E. (2020) · Breast Cancer Research · doi:10.1186/s13058-020-01376-6 · Cited by 43
Liu, W., Ren, D., Xiong, W., Jin, X., & Zhu, L. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02253-0 · Cited by 43
FBXW7-mutated colorectal cancer cells exhibit aberrant expression of phosphorylated-p53 at Serine-15
Li, N., Lorenzi, F., Kalakouti, E., Normatova, M., Babaei‐Jadidi, R., Tomlinson, I. P. M., & Nateri, A. S. (2015) · Oncotarget · doi:10.18632/oncotarget.3284 · Cited by 44
MYC-nick promotes cell migration by inducing fascin expression and Cdc42 activation
Anderson, S., Poudel, K. R., Roh‐Johnson, M., Brabletz, T., Yu, M., Borenstein‐Auerbach, N., Grady, W., Bai, J., Moens, C. B., Eisenman, R. N., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1610994113 · Cited by 43
O’Connor, H. F., & Huibregtse, J. M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2529-6 · Cited by 42
Genome evolution predicts genetic interactions in protein complexes and reveals cancer drug targets
Lu, X., Kensche, P. R., Huynen, M. A., & Notebaart, R. A. (2013) · Nature Communications · doi:10.1038/ncomms3124 · Cited by 42
Fbxw7 Limits Myelination by Inhibiting mTOR Signaling
Kearns, C. A., Ravanelli, A. M., Cooper, K., & Appel, B. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.4968-14.2015 · Cited by 42
Carrieri, F. A., & Dale, J. K. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2016.00151 · Cited by 42
Luan, H., Mohapatra, B. C., Bielecki, T. A., Mushtaq, I., Mirza, S., Jennings, T. A., Clubb, R. J., An, W., Ahmed, D., Ansari, R. E., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-16-2140 · Cited by 42
Targeting SCF E3 Ligases for Cancer Therapies
Liu, J., Peng, Y., Zhang, J., Long, J., Liu, J., & Wei, W. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-981-15-1025-0_9 · Cited by 42
Nucleolar Targeting of the Fbw7 Ubiquitin Ligase by a Pseudosubstrate and Glycogen Synthase Kinase 3
Welcker, M., Larimore, E. A., Frappier, L., & Clurman, B. E. (2011) · Molecular and Cellular Biology · doi:10.1128/mcb.01347-10 · Cited by 42
Self-citationChang, C., Lin, H., Lin, J.-K., Lin, C., Lan, Y., Wang, H.-S., Yang, S.-H., Chen, W.-S., Lin, T.-C., Jiang, J., et al. (2014) · The International Journal of Biological Markers · doi:10.5301/jbm.5000125 · Cited by 41
Zhao, J., Hu, C., Chi, J., Li, J., Chen, P., Yun, X., Li, D., Yu, Y., Li, Y., Gao, M., et al. (2016) · Oncology Reports · doi:10.3892/or.2016.4891 · Cited by 42
Merkel cell polyomavirus small T antigen induces genome instability by E3 ubiquitin ligase targeting
Kwun, H. J., Wendzicki, J. A., Shuda, Y., Moore, P. S., & Chang, Y. (2017) · Oncogene · doi:10.1038/onc.2017.277 · Cited by 45
Zhang, Q., Mady, A. S. A., Ma, Y., Ryan, C., Lawrence, T. S., Nikolovska‐Coleska, Z., Sun, Y., & Morgan, M. A. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz058 · Cited by 41
A structural view of PA2G4 isoforms with opposing functions in cancer
Stevenson, B. W., Gorman, M. A., Koach, J., Cheung, B. B., Marshall, G. M., Parker, M. W., & Holien, J. K. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.rev120.014293 · Cited by 41
Targeted Therapy in Uterine Serous Carcinoma: An Aggressive Variant of Endometrial Cancer
Black, J. D., English, D. P.-G., Roque, D. M., & Santin, A. D. (2013) · Women s Health · doi:10.2217/whe.13.72 · Cited by 41
de la Cova, C., & Greenwald, I. (2012) · Genes & Development · doi:10.1101/gad.203703.112 · Cited by 41
Characterization of novel CTNNB1 mutation in Craniopharyngioma by whole-genome sequencing
He, J., Zeng, Z., Wang, Y., Deng, J., Tang, X., Liu, F., Huang, J., Chen, H., Liang, R., Zan, X., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01468-7 · Cited by 40
Genetic profiles of cervical tumors by high‐throughput sequencing for personalized medical care
Müller, E., Brault, B., Holmes, A. M., Legros, A., Jeannot, E., Campitelli, M., Rousselin, A., Goardon, N., Frébourg, T., Krieger, S., et al. (2015) · Cancer Medicine · doi:10.1002/cam4.492 · Cited by 40
Kitagawa, K., Shibata, K., Matsumoto, A., Matsumoto, M., Ohhata, T., Nakayama, K. I., Niida, H., & Kitagawa, M. (2014) · Molecular and Cellular Biology · doi:10.1128/mcb.01549-13 · Cited by 40
Synthetic lethality-based targets for discovery of new cancer therapeutics.
Weidle, U. H., Maisel, D., & Eick, D. (2011) · PubMed · Cited by 40
Targeted next-generation sequencing of cancer genes in poorly differentiated thyroid cancer
Gerber, T. S., Schad, A., Hartmann, N., Springer, E., Zechner, U., & Musholt, T. J. (2017) · Endocrine Connections · doi:10.1530/ec-17-0290 · Cited by 40
Principles of tumorigenesis and emerging molecular drivers of SHH ‐activated medulloblastomas
Menyhárt, O., & Győrffy, B. (2019) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.762 · Cited by 40
Presenilin modulates EGFR signaling and cell transformation by regulating the ubiquitin ligase Fbw7
Rocher-Ros, V., Marco, S., Mao, J.-H., Ginés, S., METZGER, D., Chambon, P., Balmain, A., & Saura, C. A. (2010) · Oncogene · doi:10.1038/onc.2010.57 · Cited by 40
Wang, Y., Shi, S., Wang, Y., Zhang, X., Liu, X., Li, J., Li, P., Du, L., & Wang, C. (2021) · Thoracic Cancer · doi:10.1111/1759-7714.14284 · Cited by 42
Characterization of Genomic Alterations in Colorectal Liver Metastasis and Their Prognostic Value
Bao, X., Wang, K., Liu, M., Li, B., Wang, H., Jin, K., Yan, X., Zhang, H., Bao, Q., Xu, D., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.760618 · Cited by 40
KCTD2, an adaptor of Cullin3 E3 ubiquitin ligase, suppresses gliomagenesis by destabilizing c-Myc
Kim, E. J., Kim, S.-H., Jin, X. J., Jin, X., & Kim, H. (2017) · Cell Death and Differentiation · doi:10.1038/cdd.2016.151 · Cited by 39
Stieg, D. C., Willis, S. D., Ganesan, V., Ong, K. L., Scuorzo, J., Song, M., Grose, J. H., Strich, R., & Cooper, K. F. (2017) · Molecular Biology of the Cell · doi:10.1091/mbc.e17-08-0493 · Cited by 41
FBXO2, a novel marker for metastasis in human gastric cancer
Sun, X., Wang, T., Guan, Z., Zhang, C., Chen, Y., Jin, J., & Hua, D. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.12.097 · Cited by 39
Yu, J., Ding, S.-L., Chang, C., Kuo, S.-H., Chen, S., Hsu, G., Hsu, H.-M., Hou, M., Jung, L. Y., Cheng, C., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp173 · Cited by 39
Phosphorylation-dependent regulation of Notch1 signaling: the fulcrum of Notch1 signaling
Lee, H.-J., Kim, M., & Park, H.-S. (2015) · BMB Reports · doi:10.5483/bmbrep.2015.48.8.107 · Cited by 41
Rodríguez‐Blanco, J., Martı́n, V., García‐Santos, G., Herrera, F., Zapico, S. C., Antolı́n, I., & Rodrı́guez, C. (2012) · Journal of Neuroscience Research · doi:10.1002/jnr.23066 · Cited by 38
Burger, J., Merlet, J., Tavernier, N., Richaudeau, B., Arnold, A. W., Ciosk, R., Bowerman, B. A., & Pintard, L. (2013) · PLoS Genetics · doi:10.1371/journal.pgen.1003375 · Cited by 40
Liu, X., Zong, W., Li, T., Wang, Y., Xu, X., Zhou, Z., & Wang, Z. (2017) · The EMBO Journal · doi:10.15252/embj.201694443 · Cited by 38
Cyclin E2 induces genomic instability by mechanisms distinct from cyclin E1
Caldon, C. E., Sergio, C. M., Burgess, A., Deans, A. J., Sutherland, R. L., & Musgrove, E. A. (2013) · Cell Cycle · doi:10.4161/cc.23512 · Cited by 38
Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway
Wang, X., Zhang, J., Zhou, L., Sun, W., ZHENG, Z.-G., Lü, P., Gao, Y., Yang, X., Zhang, Z., Tao, K., et al. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.2981 · Cited by 38
RetractedDrug Discovery Approaches to Target E3 Ligases
Rodríguez-Gimeno, A., & Galdeano, C. (2024) · ChemBioChem · doi:10.1002/cbic.202400656 · Cited by 39
Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR
Xu, H., George, E. M., Gallo, D., Medvedev, S., Wang, X., Datta, A., Kryczka, R., Hyer, M. L., Fourtounis, J., Stocco, R., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-58183-w · Cited by 37
Murine Models of Acute Leukemia: Important Tools in Current Pediatric Leukemia Research
Jacoby, E., Chien, C. D., & Fry, T. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00095 · Cited by 44
PI3K-dependent phosphorylation of Fbw7 modulates substrate degradation and activity
Schülein‐Völk, C., Eilers, M., & Popov, N. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.05.036 · Cited by 37
Liu, J., & Nussinov, R. (2010) · Journal of Molecular Biology · doi:10.1016/j.jmb.2010.01.022 · Cited by 39
Ubiquitin-dependent regulation of transcription in development and disease
Mark, K. G., & Rapé, M. (2021) · EMBO Reports · doi:10.15252/embr.202051078 · Cited by 39
Phosphorylation prevents C/EBPβ from the calpain-dependent degradation
Zhang, Y.-Y., Li, S.-F., Qian, S.-W., Zhang, Y.-Y., Liu, Y., Tang, Q.-Q., & Li, X. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.02.058 · Cited by 37
Prognostic impact of RING box protein-1 (RBX1) expression in gastric cancer
Migita, K., Takayama, T., Matsumoto, S., Wakatsuki, K., Tanaka, T., Ito, M., Nishiwada, S., & Nakajima, Y. (2013) · Gastric Cancer · doi:10.1007/s10120-013-0318-y · Cited by 37
RBX1/ROC1-SCF E3 ubiquitin ligase is required for mouse embryogenesis and cancer cell survival
Jia, L., & Sun, Y. (2009) · Cell Division · doi:10.1186/1747-1028-4-16 · Cited by 38
States of G0 and the proliferation-quiescence decision in cells, tissues and during development
Sun, D., & Buttitta, L. (2017) · The International Journal of Developmental Biology · doi:10.1387/ijdb.160343lb · Cited by 39
Torres, S., García‐Palmero, I., Bartolomé, R. A., Fernández‐Aceñero, M. J., Roldán, E. M., Calviño, E., Segura, M. F., & Casal, J. I. (2017) · The Journal of Pathology · doi:10.1002/path.4874 · Cited by 36
Falisi, E., Novella, E., Visco, C., Guercini, N., Maura, F., Giaretta, I., Pomponi, F., Nichele, I., Finotto, S., Montaldi, A., et al. (2013) · Hematological Oncology · doi:10.1002/hon.2086 · Cited by 36
Luscan, A., Just, P., Briand‐Suleau, A., Roziers, C. B. D., Goussard, P., Nitschké, P., Vidaud, M., Avril, M.-F., Terris, B., & Pasmant, É. (2014) · British Journal of Ophthalmology · doi:10.1136/bjophthalmol-2014-305371 · Cited by 36
Regulating Fbw7 on the road to cancer
Xu, W., Taranets, L., & Popov, N. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.09.005 · Cited by 37
Jiang, J., Sun, C., Tian, S., Yu, C., Chen, M., & Zhang, H. (2016) · Tumor Biology · doi:10.1007/s13277-016-5217-5 · Cited by 36
Regulation of GATA-binding Protein 2 Levels via Ubiquitin-dependent Degradation by Fbw7
Nakajima, T., Kitagawa, K., Ohhata, T., Sakai, S., Uchida, C., Shibata, K., Minegishi, N., Yumimoto, K., Nakayama, K. I., Masumoto, K., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.613018 · Cited by 36
SCFFbxw7/hCdc4 targets cyclin E2 for ubiquitin-dependent proteolysis
Klotz, K., Cepeda, D., Tan, Y., Sun, D., Sangfelt, O., & Spruck, C. (2008) · Experimental Cell Research · doi:10.1016/j.yexcr.2008.11.017 · Cited by 36
FBXW7-Induced MTOR Degradation Forces Autophagy to Counteract Persistent Prion Infection
Xu, Y., Tian, C., Sun, J. F., Zhang, J., Ren, K., Fan, X., Wang, K., Wang, H., Yan, Y., Chen, C., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-9028-7 · Cited by 36
Keutgens, A., Shostak, K., Close, P., Zhang, X., Hennuy, B., Aussems, M., Chapelle, J.-P., Viatour, P., Gothot, A., Fillet, M., et al. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.01600-09 · Cited by 36
Zhang, W., Hong, S., Maniar, K. P., Cheng, S., Jie, C., RADEMAKER, A. W., Krensky, A. M., & Clayberger, C. (2016) · Oncogene · doi:10.1038/onc.2016.97 · Cited by 36
USP13 drives lung squamous cell carcinoma by switching lung club cell lineage plasticity
Kwon, J., Zhang, J., Mok, B., Allsup, S., Kim, C., Toretsky, J. A., & Han, C. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01892-x · Cited by 35
Distinct Interactions of EBP1 Isoforms with FBXW7 Elicits Different Functions in Cancer
Wang, Y., Zhang, P., Wang, Y., Zhan, P., Liu, C., Mao, J., & Wei, G. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2246 · Cited by 35
Exome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma
Chow, Y. P., Tan, L. P., Chai, S. J., Aziz, N. A., Choo, S. W., Lim, P. V. H., Rajadurai, P., Kornain, N. K. M., Lum, C. L., Pua, K. C., et al. (2017) · Scientific Reports · doi:10.1038/srep42980 · Cited by 35
Yamauchi, M., Urabe, Y., Ono, A., Miki, D., Ochi, H., & Chayama, K. (2017) · International Journal of Cancer · doi:10.1002/ijc.31154 · Cited by 35
Zhang, Z., Liu, M., Hu, Q., Xu, W., Liu, W., Sun, Q., Zeng, Y., Fan, G., Xu, X., Yu, X., et al. (2019) · PubMed Central · Cited by 35
E3 ligase FBXW7 restricts M2-like tumor-associated macrophage polarization by targeting c-Myc
Zhong, L., Zhang, Y., Li, M., Song, Y., Liu, D., Yang, X., Yang, D., Qu, H., Lai, L., Wang, Q., et al. (2020) · Aging · doi:10.18632/aging.202293 · Cited by 35
Noori–Daloii, M. R., Momeny, M., Yousefi, M., Golsaz‐Shirazi, F., Yaseri, M., Motamed, N., Kazemialiakbar, N., & Hashemi, S. (2010) · Medical Oncology · doi:10.1007/s12032-010-9603-3 · Cited by 35
The FBXO4 Tumor Suppressor Functions as a Barrier to Braf V600E -Dependent Metastatic Melanoma
Lee, E. K., Lian, Z., D'Andrea, K. P., Letrero, R., Sheng, W., Liu, S., Diehl, J. A., Pytel, D., Barbash, O., Schuchter, L. M., et al. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00706-13 · Cited by 37
GLIPR1 Suppresses Prostate Cancer Development through Targeted Oncoprotein Destruction
Li, L., Ren, C., Yang, G., Fattah, E. A., Goltsov, A. A., Kim, S. M., Lee, J., Park, S., DeMayo, F. J., Ittmann, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1714 · Cited by 35
Kim, H. S., Woolard, K., Lai, C., Bauer, P. O., Maric, D., Song, H., Li, A., Kotliarova, S. E., Zhang, W., & Fine, H. A. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-2594 · Cited by 36
Skp1: Implications in cancer and SCF-oriented anti-cancer drug discovery
Hussain, M., Lu, Y., Liu, Y., Su, K., Zhang, J., Liu, J., & Zhou, G. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.05.027 · Cited by 38
Loss of FBXW7 and accumulation of MCL1 and PLK1 promote paclitaxel resistance in breast cancer
Gasca, J., Flores, M. L., Giráldez, S., Ruíz‐Borrego, M., Tortolero, M., Romero, F., Japón, M. Á., & Sáez, C. (2016) · Oncotarget · doi:10.18632/oncotarget.10481 · Cited by 35
Jawa, Y., Yadav, P., Gupta, S., Mathan, S. V., Pandey, J., Saxena, A. K., Kateriya, S., Tiku, A. B., Mondal, N., Bhattacharya, J., et al. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.676948 · Cited by 36
FBW7 suppresses metastasis of colorectal cancer by inhibiting HIF1α/CEACAM5 functional axis
Li, Q., Li, Y., Li, J., Ma, Y., Dai, W., Mo, S., Xu, Y., Li, X., & Cai, S. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.24505 · Cited by 34
Dye, K. N., Welcker, M., Clurman, B. E., Roman, A., & Galloway, D. A. (2019) · PLoS Pathogens · doi:10.1371/journal.ppat.1007543 · Cited by 34
Self-citationSCFFBXW7/GSK3β-Mediated GFI1 Degradation Suppresses Proliferation of Gastric Cancer Cells
Kuai, X., Li, L., Chen, R., Wang, K., Chen, M., Cui, B., Zhang, Y., Li, J., Zhu, H., Zhou, H., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-4032 · Cited by 34
Proteasomal degradation of the tumour suppressor FBW7 requires branched ubiquitylation by TRIP12
Khan, O. M., Almagro, J., Nelson, J. K., Horswell, S. D., Encheva, V., Keyan, K. S., Clurman, B. E., Snijders, A. P., & Behrens, A. (2021) · Nature Communications · doi:10.1038/s41467-021-22319-5 · Cited by 34
Self-citationGenome-wide CRISPR screen identifies protein pathways modulating tau protein levels in neurons
Sanchez, C. G., Acker, C. M., Gray, A. J., Varadarajan, M., Song, C., Cochran, N. R., Paula, S., Lindeman, A., An, S., McAllister, G., et al. (2021) · Communications Biology · doi:10.1038/s42003-021-02272-1 · Cited by 37
HER2-Akt signaling in regulating COP9 signalsome subunit 6 and p53
Xue, Y., Chen, J., Choi, H.-H., Phan, L. M., Chou, P., Zhao, R., Yang, H., Santiago, J., Liu, M., Yeung, G. E., et al. (2012) · Cell Cycle · doi:10.4161/cc.22413 · Cited by 34
Biswas, M., Kwong, E. K., Park, E., Nagra, P., & Chan, J. Y. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.04.013 · Cited by 34
The F-box protein Cdc4/Fbxw7 is a novel regulator of neural crest development in Xenopus laevis
Almeida, A. D., Wise, H. M., Hindley, C. J., Slevin, M. K., Hartley, R. S., & Philpott, A. (2010) · Neural Development · doi:10.1186/1749-8104-5-1 · Cited by 34
Aguilar-Hernández, M., PATEL, B., Hey, F., Giblett, S. M., Belnoue-Davis, H. L., & Pritchard, C. A. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.02.009 · Cited by 34
FBXW 7 deletion contributes to lung tumor development and confers resistance to gefitinib therapy
Xiao, Y., Yin, C., Wang, Y., Lv, H., Wang, W., Huang, Y., Pérez‐Losada, J., Snijders, A. M., Mao, J., & Zhang, P. (2018) · Molecular Oncology · doi:10.1002/1878-0261.12200 · Cited by 34
Genetic mutations in human rectal cancers detected by targeted sequencing
Bai, J., Gao, J., Mao, Z., Wang, J., Li, J., Li, W., Lei, Y., Li, S., Wu, Z., Tang, C., et al. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.71 · Cited by 33
Molecular characterization of oral squamous cell carcinoma using targeted next‐generation sequencing
Er, T., Wang, Y., Chen, C., Herreros‐Villanueva, M., Liu, T., & Yuan, S. F. (2015) · Oral Diseases · doi:10.1111/odi.12357 · Cited by 33
Tu, K., Zheng, X. M., Yin, G., ZAN, X., Yao, Y., & Liu, Q. (2012) · Molecular Medicine Reports · doi:10.3892/mmr.2012.953 · Cited by 33
Regulation of F-box proteins by noncoding RNAs in human cancers
Lin, M., Xu, Y., Gao, Y., Pan, C., Zhu, X., & Wang, Z. P. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.09.008 · Cited by 33
Xanthohumol suppresses glioblastoma via modulation of Hexokinase 2 -mediated glycolysis
Yuan, J., Peng, G., Xiao, G., Yang, Z., Huang, J., Liu, Q., Yang, Z., & Liu, D. (2020) · Journal of Cancer · doi:10.7150/jca.33045 · Cited by 33
Synaptic Protein Degradation Controls Sexually Dimorphic Circuits through Regulation of DCC/UNC-40
Salzberg, Y., Pechuk, V., Gat, A., Setty, H., Sela, S., & Oren‐Suissa, M. (2020) · Current Biology · doi:10.1016/j.cub.2020.08.002 · Cited by 33
Yi, X., Lou, L., Wang, J., Xiong, J., & Zhou, S. (2021) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-021-04238-w · Cited by 33
Rack1 protects N-terminal phosphorylated c-Jun from Fbw7-mediated degradation
Zhang, J., Zhu, F., Li, X., Dong, Z., Xu, Y., Peng, C., Li, S., Cho, Y.-Y., Yao, K., Zykova, T. A., et al. (2011) · Oncogene · doi:10.1038/onc.2011.369 · Cited by 33
Lin, J., Ji, A., Qiu, G., Feng, H., Li, J., Li, S., Zou, Y., Cui, Y., Song, C., He, H., et al. (2018) · Cancer Science · doi:10.1111/cas.13528 · Cited by 33
Zhou, Z., Zhang, B., Deng, Y., Deng, S., Li, J., Wei, W., Wang, Y., Wang, J., Feng, Z., Che, M., et al. (2024) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-024-02959-3 · Cited by 33
Xu, Y., Swartz, K. L., Siu, K. T., Bhattacharyya, M., & Minella, A. C. (2013) · Oncogene · doi:10.1038/onc.2013.289 · Cited by 33
Peng, D., Wang, Z., Huang, A., Zhao, Y. B., & Qin, F. X.-F. (2016) · The Journal of Immunology · doi:10.4049/jimmunol.1601009 · Cited by 32
FBXW7 Triggers Degradation of KMT2D to Favor Growth of Diffuse Large B-cell Lymphoma Cells
Saffie, R., Zhou, N., Rolland, D. C. M., Önder, Ö., Basrur, V., Campbell, S. L., Wellen, K. E., Elenitoba‐Johnson, K. S. J., Capell, B. C., & Busino, L. (2020) · Cancer Research · doi:10.1158/0008-5472.can-19-2247 · Cited by 32
Insulin action and resistance are dependent on a GSK3β-FBXW7-ERRα transcriptional axis
Xia, H., Scholtes, C., Dufour, C. R., Ouellet, C., Ghahremani, M., & Giguère, V. (2022) · Nature Communications · doi:10.1038/s41467-022-29722-6 · Cited by 33
Isoform‐Specific SCFFbw7 Ubiquitination Mediates Differential Regulation of PGC‐1α
Trausch‐Azar, J. S., Abed, M., Orian, A., & Schwartz, A. L. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24812 · Cited by 32
Metadata
- Authors
- Welcker, M., & Clurman, B. E.
- Affiliations
- Fred Hutch Cancer Center (US)
- University of Washington (US)
- Corresponding author
- Welcker, Markus
- Venue
- Nature Reviews Cancer
- Published
- 2008-02
- Volume
- 8
- Issue
- 2
- Pages
- 83-93
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2142183096
- Cited by
- 1,084
- References
- 120
- Citations by year
- 2026: 33 · 2025: 34 · 2024: 34 · 2023: 38 · 2022: 53 · 2021: 67 · 2020: 64 · 2019: 69 · 2018: 67 · 2017: 68 · 2016: 74 · 2015: 77 · 2014: 73 · 2013: 82 · 2012: 76
- FWCI
- 2.91
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Heart, Lung, and Blood Institute (P01HL084205)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Keywords
- FBXW7, SCF ubiquitin ligase, tumour suppressor, MYC degradation, cyclin E, notches, c-Jun, chromosomal instability, carcinogenesis, cancer-associated mutations, cell division, cell growth, cell differentiation
- MeSH terms
- F-Box-WD Repeat-Containing Protein 7, Animals, Cell Differentiation, Cell Division, Humans, Models, Biological, Mutation, Neoplasms, Gene Expression Regulation, Neoplastic, Cell Cycle Proteins, Dimerization, Cyclin E, Ubiquitin-Protein Ligases, F-Box Proteins, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review